N-alkyl-adamantyl triazinyl benzamide derivatives
US6927219B2 · kind B2 · utility
8Cited by
14References
11Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Nov 12, 2002 |
| Grant date | Aug 9, 2005 |
| Priority date | — |
| Expiry date | Nov 12, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel to N-alkyl adamantyl triazinyl benzylamide derivatives of formmula I: and to processs for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention are useful in the treatment of inflammation, osteoarthritis, rhematoid arthritis, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.